1. Home
  2. Stocks
  3. Granules Share Price
  • Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Granules India Share Price

    Mid Cap
    ₹549.1
    -20.65 (-3.62%)
    07 October, 2024 13:08 BSE: 532482 NSE: GRANULES ISIN: INE101D01020

    Start SIP in Granules India

    Start SIP

    Granules India Performance

    Day Range

    • Low 538
    • High 574
    ₹ 549

    52 Week Range

    • Low 319
    • High 721
    ₹ 549
    • Open Price571
    • Previous Close570
    • Volume2048998

    Granules India Chart

    • Over 1 Month -19.85%
    • Over 3 Month + 4.85%
    • Over 6 Month + 21.88%
    • Over 1 Year + 52.31%

    Granules India Key Statistics

    P/E Ratio 27
    PEG Ratio 2.1
    Market Cap Cr 13,309
    Price to Book Ratio 4.1
    EPS 18.1
    Dividend 0.3
    Relative Strength Index 43.88
    Money Flow Index 59.08
    MACD Signal -21.58
    Average True Range 26.94

    Granules India F&O

    Granules India Futures Granules India Option Chain

    Granules India Investment Rating

    • Master Rating:

    • Granules India has an operating revenue of Rs. 4,700.72 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 12% is healthy, ROE of 12% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 16% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Granules India Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 8529409841,0098211,014
    Operating Expenses Qtr Cr 675751738801664797
    Operating Profit Qtr Cr 177189247208157217
    Depreciation Qtr Cr 363636363538
    Interest Qtr Cr 182020181514
    Tax Qtr Cr 323949402743
    Net Profit Qtr Cr 949714311680125
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,7613,941
    Operating Expenses Annual Cr 2,9543,093
    Operating Profit Annual in Cr 801838
    Depreciation Cr 144146
    Interest Annual Cr 7239
    Tax Annual Cr 155165
    Net Profit Annual Cr 436499
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 317664
    Cash from Investing Activity Annual Cr -303-96
    Cash from Financing Annual Activity Cr 26-519
    Net Cash Flow Annual Cr 4048
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 3,1112,699
    Fixed Assets Annual Cr 1,3771,393
    Total Non Current Assets Annual Cr 2,3722,185
    Total Current Assets Annual Cr 2,6342,318
    Total Assets Annual Cr 5,0064,503
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 128112
    ROE Annual % 1418
    ROCE Annual % 2024
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2122
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,1801,1761,1561,1899861,196
    Operating Expenses Qtr Cr 921920905977849967
    Operating Profit Qtr Cr 259256250213137228
    Depreciation Qtr Cr 535352534949
    Interest Qtr Cr 272929262219
    Tax Qtr Cr 474644341844
    Net Profit Qtr Cr 13513012610248120
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 4,5114,526
    Operating Expenses Annual Cr 3,6503,598
    Operating Profit Annual in Cr 856914
    Depreciation Cr 207184
    Interest Annual Cr 10656
    Tax Annual Cr 142171
    Net Profit Annual Cr 405517
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 439739
    Cash from Investing Activity Annual Cr -360-191
    Cash from Financing Annual Activity Cr 8-440
    Net Cash Flow Annual Cr 87107
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 3,2262,835
    Fixed Assets Annual Cr 2,3672,150
    Total Non Current Assets Annual Cr 2,6162,330
    Total Current Assets Annual Cr 2,9052,574
    Total Assets Annual Cr 5,5214,905
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 133117
    ROE Annual % 1318
    ROCE Annual % 1924
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1921
    Invest in Granules India

    Granules India Technicals

    EMA & SMA

    Current Price
    ₹549.1
    -20.65 (-3.62%)
    pointer
    • Bullish Moving Average
    • ___
    • 4
    • Bearish Moving Average
    • ___
    • 12
    • 20 Day
    • ₹585.23
    • 50 Day
    • ₹593.73
    • 100 Day
    • ₹560.79
    • 200 Day
    • ₹503.57
    • 20 Day
    • ₹582.58
    • 50 Day
    • ₹628.84
    • 100 Day
    • ₹550.07
    • 200 Day
    • ₹487.56

    Granules India Resistance and Support

    PIVOT
    ₹576.25
    Resistance
    First Resistance 592.50
    Second Resistance 615.25
    Third Resistance 631.50
    RSI 43.88
    MFI 59.08
    MACD Single Line -21.58
    MACD -18.75
    Support
    First Support 553.50
    Second Support 537.25
    Third Supoort 514.50

    Granules India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 6,005,608 206,532,859 34.39
    Week 7,286,596 265,887,897 36.49
    1 Month 7,507,060 261,020,478 34.77
    6 Month 2,891,613 101,669,114 35.16

    Granules India Result Highlights

    Granules India Synopsis

    NSE-Medical-Diversified

    Granules India L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3755.09 Cr. and Equity Capital is Rs. 24.24 Cr. for the Year ended 31/03/2024. Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1991PLC012471 and registration number is 012471.
    Market Cap 13,809
    Sales 3,786
    Shares in Float 14.78
    No of funds 195
    Yield 0.26
    Book Value 4.44
    U/D Vol ratio 0.8
    LTDebt / Equity 2
    Alpha 0.09
    Beta 0.95

    Granules India Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 38.87%41.96%41.96%41.96%
    Mutual Funds 9.16%7.09%7.05%3.94%
    Insurance Companies 4.69%3.59%3.09%2.92%
    Foreign Portfolio Investors 20.39%19.57%18.78%21.48%
    Financial Institutions/ Banks
    Individual Investors 18.78%19.38%20.39%21.12%
    Others 8.11%8.41%8.73%8.58%

    Granules India Management

    Name Designation
    Dr. Krishna Prasad Chigurupati Chairman & Managing Director
    Dr. K V S Ram Rao Joint Managing Director & CEO
    Mr. Harsha Chigurupati Ind. Non-Executive Director
    Mrs. Uma Devi Chigurupati Ind. Non-Executive Director
    Mr. Kolli Basava Sankar Rao Non Exe.Non Ind.Director
    Dr. Saumen Chakraborty Ind. Non-Executive Director
    Mrs. Sucharita Rao Palepu Ind. Non-Executive Director
    Dr. Sethurathnam Ravi Ind. Non-Executive Director
    Mr. Arun Sawhney Ind. Non-Executive Director
    Mr. Kapil Kumar Mehan Ind. Non-Executive Director
    Mrs. Priyanka Chigurupati Ind. Non-Executive Director
    Mr. Rajiv Pritidas Kakodkar Ind. Non-Executive Director

    Granules India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Granules India Corporate Action

    Date Purpose Remarks
    2024-07-30 Quarterly Results
    2024-05-15 Audited Results & Final Dividend
    2024-01-23 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-09 Quarterly Results
    Date Purpose Remarks
    2023-08-03 FINAL Rs.1.50 per share(150%)Final Dividend
    2022-02-18 INTERIM Re.0.25 per share (25%) Third Interim Dividend
    2021-11-25 INTERIM Re.0.25 per share (25%) Second Interim Dividend
    2021-08-06 INTERIM Rs.0.25 per share(25%)First Interim Dividend
    2021-02-09 INTERIM Rs.0.25 per share (25%) Third Interim Dividend

    Granules India MF Shareholding

    Name Amount(cr)
    Kotak Equity Arbitrage Fund Growth 53,423
    SBI Arbitrage Opportunities Fund Regular Growth 32,415
    Axis Midcap Fund Growth 31,322
    Quant Small Cap Fund Growth 25,535
    ICICI Prudential Equity Arbitrage Fund Regular Growth 24,111

    About Granules India

    Granules India Ltd. is vertically integrated pharmaceutical company based in India, specializing in manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), & finished dosages. Established in 1984, company has strong presence in global pharmaceutical market, supplying its products to over 300 customers in more than 60 countries. Granules India's focus on cost-efficient manufacturing, quality assurance, & regulatory compliance has enabled it to become trusted partner for leading pharmaceutical companies worldwide. company's commitment to innovation & expansion has driven its growth in highly competitive pharmaceutical industry.

    With six tons of batch processing capacity, it is one of biggest PFI makers in India. Since its PFIs are made to transfer straight from drums to hoppers, it has established itself as top supplier to major international pharmaceutical corporations. 
    The strategy focus on high-value formulations & drop in API sales are to blame for change in revenue contribution.

    Beyond top five heritage items, company is expanding its product line; as of FY24, new products account for 25% of total sales, up from 19% in FY22.
     

    Granules India FAQs

    What is Share Price of Granules India ?

    Granules India share price is ₹549 As on 07 October, 2024 | 12:54

    What is the Market Cap of Granules India ?

    The Market Cap of Granules India is ₹13308.5 Cr As on 07 October, 2024 | 12:54

    What is the P/E ratio of Granules India ?

    The P/E ratio of Granules India is 27 As on 07 October, 2024 | 12:54

    What is the PB ratio of Granules India ?

    The PB ratio of Granules India is 4.1 As on 07 October, 2024 | 12:54

    Is it good time to buy Granules India shares?

    Consider company's market position in pharmaceutical industry & its growth prospects before investing.
     

    What are most important metrics that can help to analyze share price of Granules India?

    Key metrics include revenue from key products, profit margins, & regulatory approvals.

    How can you buy shares from Granules India?

    Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Granules India share, you can then put order as you prefer.

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.